Blood Group Typing Market By Product (Instruments, Reagents & Kits) , By Test Type (ABO Tests, Antigen Typing, Antibody Screening, Cross-Matching Tests, HLA Typing) By Technique (Serology Tests, Molecular Tests) By End User (Hospital, Blood Banks) : Globa

Blood Group Typing Market By Product (Instruments, Reagents & Kits) , By Test Type (ABO Tests, Antigen Typing, Antibody Screening, Cross-Matching Tests, HLA Typing) By Technique (Serology Tests, Molecular Tests) By End User (Hospital, Blood Banks) : Global Opportunity Analysis and Industry Forecast, 2024-2033

The blood group typing market was valued at $2.0 billion in 2023, and is projected to reach $4.8 billion by 2033, growing at a CAGR of 9.4% from 2024 to 2033.

Blood group typing is the process of determining an individual's blood group based on the presence or absence of specific antigens on the surface of red blood cells. These antigens are molecules that can trigger an immune response, and they vary across different blood groups, making them crucial in ensuring compatibility in blood transfusions, organ transplants, and pregnancy management. Blood group typing helps to prevent adverse reactions and improve patient outcomes in clinical settings by identifying compatible donors and recipients for transfusions and other medical interventions.

Increase in rates of surgeries, trauma cases, and chronic diseases have amplified the demand for blood transfusions, necessitating accurate blood group typing to prevent incompatible transfusions. A study by the World Health Organization in 2023 estimated that around 118.4 million blood donations are collected globally each year, highlighting the critical role of blood group typing to ensure safe and compatible transfusions. In addition, alarming rise in prevalence of chronic diseases notably contributes toward the market growth. This is attributed to the fact that conditions such as cancer and severe anemia, which often require repeated blood transfusions, are driving the need for precise blood typing to ensure safe and compatible transfusions. As pe a 2023 study published by the World Health Organization, approximately 17 million individuals die from a chronic condition each year. Moreover, rise in risk of transfusion-transmitted infections acts as the key driving force of the global market. This is attributed to the fact that transfusion-transmitted infections require rigorous blood typing and screening, thus bolstering the demand for advanced testing methods to ensure the safety of blood supplies. However, high cost of blood typing instruments and molecular typing methods restrains the market growth. Furthermore, dearth of skilled technicians to operate advanced equipment or carry out molecular techniques acts as the key deterrent factor of the global market. On the contrary, the development of automated, rapid, and point-of-care blood typing systems has streamlined testing, making it more accessible and efficient. Innovations in microarray and molecular typing methods have also enhanced accuracy. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.

The global blood group typing industry is segmented on the basis of product, test type, technology, end user, and region. By product, the market is classified into instruments, kits, and reagents. On the basis of test type, it is divided into ABO Tests, antigen typing, antibody screening, cross-matching tests, and HLA typing. Depending on technology, it is segregated into serology tests and molecular tests. As per end user, it is fragmented into hospital-based laboratories and blood banks. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the reagents & kits segment dominated the market, in terms of share, in 2023.

On the basis of test type, the antigen typing segment garnered the largest share in 2023.

Depending on technology, the serology test acquired the highest share of the blood group typing market in 2023.

As per end user, the blood banks segment exhibited the highest growth, in terms of share, in 2023.

Region wise, North America held a dominant position in the market in 2023; however, Asia-Pacific is expected to register the highest CAGR from 2024 to 2033.

Competition Analysis

Competitive analysis and profiles of the major players in the global blood group typing market include Quotient Limited, CareDx Inc., Agena Bioscience, Inc., Diagast S.A., Illumina, Inc., Grifols, S.A., Immucor, Inc, Bio-Rad Laboratories, Inc. , Thermo Fisher Scientific Inc., Merck KGaA These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Key Market Segments

By Product

Instruments
Reagents Kits

By Test Type

ABO Tests
Antigen Typing
Antibody Screening
Cross-Matching Tests
HLA Typing

By Technique

Serology Tests
Molecular Tests

By End User

Hospital
Blood Banks

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Quotient Limited
CareDx Inc.
Agena Bioscience, Inc.
Diagast S.A.
Illumina, Inc.
Grifols, S.A.
Immucor, Inc
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
Merck KGaA